LEP and obesity due to melanocortin 4 receptor deficiency: Therapeutic strategies aimed at restoring AMPK activation, balancing the effects of ghrelin and leptin, and preserving the integrity of gap junctions represent potential approaches for the treatment of metabolic and inflammatory syndromes associated with obesity [88,92,96,97,99].